Singular Genomics Systems Inc

NASDAQ:OMIC

5.89

-0.29 (-4.66%)

5:42:59 PM EDT: $6.06 +0.17 (+2.85%)

Market Cap (Intraday)	14.02M
Current PE	N/A
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$0.83 Million
Adjusted EPS	-$8.05

See more estimates

10-Day MA	$6.43
50-Day MA	$7.52
200-Day MA	$11.86

See more pivots

Singular Genomics Systems Inc Stock, NASDAQ:OMIC

3010 Science Park Road, Suite 100, San Diego, California 92121

United States of America

Phone: +1.858.333.7830

Number of Employees: 265

http://www.singulargenomics.com

Description

Singular Genomics Systems, Inc. engages in the development and commercialization of proprietary sequencing solutions. It develops two integrated solutions: G4 Instrument and PX Instrument. The G4 Instrument operates as a benchtop next generation sequencer designed to produce fast and accurate genetic sequencing results. The PX Instrument combines single cell and spatial analysis, genomics, and proteomics in one integrated instrument providing a versatile multiomics solution. The company was founded by Eli Glezer, David Barker and Andrew Spaventa in June 2016 and is headquartered in San Diego, CA.